We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Marker Predicts Patients Most Likely to Benefit Longest From Two Popular Cancer Drugs

News   Sep 11, 2013

 
Molecular Marker Predicts Patients Most Likely to Benefit Longest From Two Popular Cancer Drugs
 
 
 

RELATED ARTICLES

Sleep-inducing Blood Metabolites Associated With CSF Amyloid Burden

News

Blood concentrations of fatty molecules which induce sleep were higher in those participants in the study with amyloid in the brain, the peptide used to diagnose Alzheimer’s disease.

READ MORE

Altered Tau Levels in Spinal Fluid of Athletes After Multiple Concussions

News

In a group of former professional athletes who experienced multiple concussions, a new study has found that approximately half the group had higher than normal levels of a protein called tau in their cerebrospinal fluid.

READ MORE

Biomarker for Chronic Fatigue Syndrome Identified

News

People suffering from a debilitating and often discounted disease known as chronic fatigue syndrome may soon have something they’ve been seeking for decades: scientific proof of their ailment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE